This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Innovations by Lena Hedstróm
Introduction
Lena Hedstróm is a notable inventor based in Täby, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work at AstraZeneca AB. Her research focuses on the development of stable crystalline forms of pharmaceutical compounds.
Latest Patents
Lena holds a patent for "Crystalline forms of EtO2C-CH2-(R)Cgi-Aze-Pab-OH." This invention provides a pharmaceutically-acceptable salt of EtOC—CH—(R)Cgl-Aze-Pab-OH in a substantially crystalline form. The crystalline forms of this compound exhibit high chemical and solid-state stability compared to their amorphous counterparts, making them valuable in pharmaceutical applications.
Career Highlights
Throughout her career, Lena has demonstrated a commitment to advancing pharmaceutical science. Her work at AstraZeneca AB has positioned her as a key player in the development of stable drug formulations. She has successfully navigated the complexities of pharmaceutical research, contributing to the safety and efficacy of new medications.
Collaborations
Lena collaborates with talented colleagues, including Anita Lundblad and Daniel Edvardsson. These partnerships enhance her research efforts and contribute to the innovative environment at AstraZeneca AB.
Conclusion
Lena Hedstróm's contributions to pharmaceutical innovation through her patent and collaborative efforts highlight her importance in the field. Her work continues to influence the development of stable pharmaceutical compounds, ensuring better outcomes for patients.